相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。AMG 416 (velcalcetide) is a novel peptide for the treatment of secondary hyperparathyroidism in a single-dose study in hemodialysis patients
Kevin J. Martin et al.
KIDNEY INTERNATIONAL (2014)
Velcalcetide (AMG 416), a novel peptide agonist of the calcium-sensing receptor, reduces serum parathyroid hormone and FGF23 levels in healthy male subjects
Kevin J. Martin et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
Magnesium modulates parathyroid hormone secretion and upregulates parathyroid receptor expression at moderately low calcium concentration
Maria E. Rodriguez-Ortiz et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
Cinacalcet Upregulates Calcium-Sensing Receptors of Parathyroid Glands in Hemodialysis Patients
Keiichi Sumida et al.
AMERICAN JOURNAL OF NEPHROLOGY (2013)
Calcium-Mediated Parathyroid Hormone Suppression to Assess Progression of Secondary Hyperparathyroidism During Treatment Among Incident Dialysis Patients
M. Rodriguez et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
The Clinical Course of Treated Hyperparathyroidism Among Patients Receiving Hemodialysis and the Effect of Cinacalcet: The EVOLVE Trial
Patrick S. Parfrey et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Efficacy of cinacalcet with low-dose vitamin D in incident haemodialysis subjects with secondary hyperparathyroidism
Pablo Urena-Torres et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Cinacalcet in Patients with Chronic Kidney Disease: A Cumulative Meta-Analysis of Randomized Controlled Trials
Suetonia C. Palmer et al.
PLOS MEDICINE (2013)
The efficacy of cinacalcet combined with conventional therapy on bone and mineral metabolism in dialysis patients with secondary hyperparathyroidism: a meta-analysis
Dan Li et al.
ENDOCRINE (2013)
Pharmacology of AMG 416 (Velcalcetide), a Novel Peptide Agonist of the Calcium-Sensing Receptor, for the Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients
Sarah Walter et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
New concepts in calcium-sensing receptor pharmacology and signalling
Donald T. Ward et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Behind the curtain: cellular mechanisms for allosteric modulation of calcium-sensing receptors
Alice Cavanaugh et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
The role of the calcium-sensing receptor in human disease
Bryan K. Ward et al.
CLINICAL BIOCHEMISTRY (2012)
Calcium-sensing receptor, calcimimetics, and cardiovascular calcifications in chronic kidney disease
Pablo A. Urena Torres et al.
KIDNEY INTERNATIONAL (2012)
Efficacy and safety of cinacalcet for the treatment of secondary hyperparathyroidism in patients with advanced chronic kidney disease before initiation of regular dialysis
Jesus Montenegro et al.
NEPHROLOGY (2012)
Effect of Cinacalcet on Cardiovascular Disease in Patients Undergoing Dialysis
Glenn M. Chertow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Effects and Safety of Calcimimetics in End Stage Renal Disease Patients with Secondary Hyperparathyroidism: A Meta-Analysis
Qian Zhang et al.
PLOS ONE (2012)
Cinacalcet for the Treatment of Hyperparathyroidism in Kidney Transplant Recipients: A Systematic Review and Meta-analysis
Jordana B. Cohen et al.
TRANSPLANTATION (2012)
Effect of Calcium and the Calcimimetic AMG 641 on Matrix-Gla Protein in Vascular Smooth Muscle Cells
Francisco J. Mendoza et al.
CALCIFIED TISSUE INTERNATIONAL (2011)
Secondary Hyperparathyroidism: Pathogenesis, Disease Progression, and Therapeutic Options
John Cunningham et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Discovery of a Calcimimetic with Differential Effects on Parathyroid Hormone and Calcitonin Secretion
Charles Henley et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Characterization of Highly Efficacious Allosteric Agonists of the Human Calcium-Sensing Receptor
Jian-Nong Ma et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis
Paolo Raggi et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Does it Matter How Parathyroid Hormone Levels are Suppressed in Secondary Hyperparathyroidism?
Jason R. Stubbs et al.
SEMINARS IN DIALYSIS (2011)
Cinacalcet as alternative treatment for primary hyperparathyroidism: achievements and prospects
Leonidas H. Duntas et al.
ENDOCRINE (2011)
Cinacalcet hydrochloride treatment significantly improves all-cause and cardiovascular survival in a large cohort of hemodialysis patients
Geoffrey A. Block et al.
KIDNEY INTERNATIONAL (2010)
Beneficial effect of cinacalcet in a child with familial hypocalciuric hypercalcemia
Uri S. Alon et al.
PEDIATRIC NEPHROLOGY (2010)
Is It Worth Correcting Hyperparathyroidism if Hyperphosphatemia and Hypocalcemia Worsen? A Cinacalcet Story
Kamyar Kalantar-Zadeh et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2009)
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Cinacalcet HCl in Participants With CKD Not Receiving Dialysis
Michel Chonchol et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2009)
Long-Term Cinacalcet HCl Treatment Improved Bone Metabolism in Japanese Hemodialysis Patients with Secondary Hyperparathyroidism
Takashi Shigematsu et al.
AMERICAN JOURNAL OF NEPHROLOGY (2009)
The calcimimetic R-568 retards uremia-enhanced vascular calcification and atherosclerosis in apolipoprotein E deficient (apoE-/-) mice
Ognen Ivanovski et al.
ATHEROSCLEROSIS (2009)
The calcium-sensing receptor regulates parathyroid hormone gene expression in transfected HEK293 cells
Hillel Galitzer et al.
BMC BIOLOGY (2009)
Calcification is associated with loss of functional calcium-sensing receptor in vascular smooth muscle cells
Masih-ul Alam et al.
CARDIOVASCULAR RESEARCH (2009)
Regulation of Cellular Signal Transduction Pathways by the Extracellular Calcium-Sensing Receptor
Sarah C. Brennan et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2009)
A calcimimetic (R-568), but not calcitriol, prevents vascular remodeling in uremia
Nadezda Koleganova et al.
KIDNEY INTERNATIONAL (2009)
Cinacalcet and achievement of the NKF/K-DOQI(TM) recommended target values for bone and mineral metabolism in real-world clinical practice-the ECHO observational study
Pablo Urena et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Direct upregulation of parathyroid calcium-sensing receptor and vitamin D receptor by calcimimetics in uremic rats
Francisco J. Mendoza et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2009)
Cinacalcet Reduces the Set Point of the PTH-Calcium Curve
Casimiro Valle et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Parathyroidectomy for Secondary Hyperparathyroidism in the Era of Calcimimetics
Yoshihiro Tominaga et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2008)
Cinacalcet hydrochloride reduces the serum calcium concentration in inoperable parathyroid carcinoma
S. J. Silverberg et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Extracellular calcium-sensing receptor is functionally expressed in human artery
Guerman Molostvov et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2007)
The calcimimetic R-568 increases vitamin D receptor expression in rat parathyroid glands
M. E. Rodriguez et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2007)
Extracellular calcium sensing in rat aortic vascular smooth muscle cells
Sanela Smajilovic et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Calcimimetic R-568 decreases extraosseous calcifications in uremic rats treated with calcitriol
Ignacio Lopez et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Increased parathyroid hormone gene expression in secondary hyperparathyroidism of experimental uremia is reversed by calcimimetics: Correlation with posttranslational modification of the trans acting factor AUF1
Ronen Levi et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism
J Cunningham et al.
KIDNEY INTERNATIONAL (2005)
Evidence in favor of a calcium-sensing receptor in arterial endothelial cells - Studies with calindol and calhex 231
AH Weston et al.
CIRCULATION RESEARCH (2005)
Successful treatment of hypercalcemia with cinacalcet in renal transplant recipients with persistent hyperparathyroidism
AL Serra et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2005)
The calcimimetic cinacalcet normalizes serum calcium in renal transplant patients with persistent hyperparathyroidism
AE Kruse et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2005)
Cinacalcet hydrochloride is an effective treatment for secondary hyperparathyroidism in patients with CKD not receiving dialysis
C Charytan et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2005)
Predictors and consequences of altered mineral metabolism: The Dialysis Outcomes and Practice Patterns Study
EW Young et al.
KIDNEY INTERNATIONAL (2005)
Association between primary hyperparathyroidism and increased body weight: A meta-analysis
MJ Bolland et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in Hemodialysis and peritoneal dialysis: A randomized, double-blind, multicenter study
JS Lindberg et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
The calcium-sensing receptor: a key factor in the pathogenesis of secondary hyperparathyroidism
M Rodriguez et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2005)
Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States medicare population, 1998 to 1999
RN Foley et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Positive and negative allosteric modulators of the Ca2+-sensing receptor interact within overlapping but not identical binding sites in the transmembrane domain
C Petrel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis
GA Block et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Pharmacodynamics of the type II calcimimetic compound cinacalcet HCl
EF Nemeth et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
AS Go et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
N2-benzyl-N1-(1-(1-naphthyl)ethyl)-3-phenylpropane-1,2-diamines and conformationally restrained indole analogues:: development of calindol as a new calcimimetic acting at the calcium sensing receptor
A Kessler et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Regulation of parathyroid vitamin D receptor expression by extracellular calcium
B Garfia et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2002)
The search for calcium receptor antagonists (calcilytics)
EF Nemeth
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2002)
A calcimimetic agent lowers plasma parathyroid hormone levels in patients with secondary hyperparathyroidism
WG Goodman et al.
KIDNEY INTERNATIONAL (2000)
Evidence for a calcium-sensing receptor in the vascular smooth muscle cells of the spiral modiolar artery
K Wonneberger et al.
JOURNAL OF MEMBRANE BIOLOGY (2000)
分享论文
